Core Viewpoint - A class action lawsuit has been filed against Cepton, Inc. alleging that the company misled investors regarding its acquisition by Koito Manufacturing Co., Ltd. [1][2] Group 1: Allegations - The lawsuit claims that Cepton did not disclose a credible third-party bid that valued the company at more than double the acquisition price offered by Koito, which was $3.17 per share [3] - It is alleged that Cepton's Board of Directors failed to adequately explore the third-party offer and did not disclose its terms when recommending the Koito acquisition to shareholders [3] - As a result of these actions, shareholders were deprived of the opportunity to make an informed decision regarding the acquisition [3] Group 2: Legal Proceedings - Shareholders interested in participating as lead plaintiffs in the class action must file their papers with the court by December 8, 2025 [4] - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4] Group 3: Firm Background - Robbins LLP is noted for its focus on shareholder rights litigation, helping shareholders recover losses and improve corporate governance since 2002 [5]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against The Trade Desk, Inc. due to a class action complaint alleging breaches of fiduciary duties by the company's board of directors during a specified class period [1][2]. Group 1: Class Action Details - The class action alleges that during the class period from May 9, 2024, to February 12, 2025, Trade Desk made materially false and misleading statements regarding its business operations and prospects [2]. - Specific allegations include significant execution challenges in rolling out the Kokai platform, which delayed its rollout and negatively impacted revenue growth [2]. Group 2: Next Steps for Investors - Long-term stockholders of Trade Desk are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and potential claims related to the class action [3]. Group 3: About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Alto Neuroscience, Inc. (NYSE:ANRO) on behalf of long-term stockholders due to a class action complaint alleging breaches of fiduciary duties by the board of directors [1][6]. Company Overview - Alto Neuroscience, Inc. is facing scrutiny following a class action complaint filed on July 21, 2025, concerning the period from February 2, 2024, to October 22, 2024 [1]. - The complaint alleges that the Offering Documents related to Alto's IPO were negligently prepared and that the effectiveness of ALTO-100 in treating Major Depressive Disorder (MDD) was overstated [6]. Financial Impact - On October 22, 2024, Alto announced that ALTO-100 did not meet its primary endpoint in a Phase 2b trial for MDD, leading to a significant stock price drop of $10.17 per share, or 69.99%, closing at $4.36 per share on October 23, 2024 [6].

Core Viewpoint - A class action lawsuit has been filed against Fortinet, Inc. for allegedly misrepresenting the impact of unit upgrades of its FortiGate firewalls, leading to significant stock price decline when the truth was revealed [1][2][3]. Group 1: Allegations - The lawsuit claims that Fortinet failed to disclose the difficulty in predicting the total number of FortiGates requiring an upgrade [2]. - It is alleged that customers had excess firewall capacity from previous purchases, reducing the necessity for upgrades [2]. - The complaint states that the refresh of the firewalls had minimal business impact, as it represented only a small percentage of the company's business due to the age of the products [2]. Group 2: Stock Price Impact - Following the revelation of these allegations, Fortinet's stock price dropped over 22%, from $96.58 per share on August 6, 2025, to $75.30 per share on August 7, 2025 [3]. Group 3: Class Action Participation - Shareholders may be eligible to participate in the class action against Fortinet and can contact Robbins LLP if they wish to serve as lead plaintiff [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Group 4: Firm Background - Robbins LLP is recognized for its leadership in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - A class action lawsuit has been filed against Quanex Building Products Corporation for failing to disclose significant operational issues related to its Tyman acquisition, which led to a substantial decline in stock price when the information was revealed [2][3]. Group 1: Allegations and Issues - The lawsuit alleges that Quanex's maintenance procedures and policies at its Tyman Mexico facility were significantly underinvested, leading to degraded tooling and equipment conditions [2]. - It is claimed that these operational issues were previously identified by the company but not disclosed, resulting in misleading positive statements about its business and prospects [2]. Group 2: Stock Price Impact - Following the revelation of these issues, Quanex's stock price dropped by $2.73, or 13.1%, closing at $18.18 per share on September 5, 2025 [3]. - The stock continued to decline, falling an additional $1.98, or 10.9%, to close at $16.20 per share on September 8, 2025 [3]. Group 3: Class Action Participation - Shareholders may be eligible to participate in the class action, with a deadline to file as lead plaintiff by November 18, 2025 [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4].

, /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. (NASDAQ: CYTK) securities between December 27, 2023 and May 6, 2025. Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. For mor ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Strategy (MSTR) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Strategy between April 30, 2024 and April 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recogn ...

Core Viewpoint - A class action lawsuit has been filed against Fly-E Group, Inc. for allegedly misleading investors about its revenue projections and sales performance during a specified period [1][2]. Company Overview - Fly-E Group, Inc. operates in the electric vehicle sector, specifically designing, installing, and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand in the United States, Mexico, and Canada [1]. Allegations - The lawsuit claims that Fly-E Group misrepresented its revenue outlook and sales expectations, creating a false impression of reliable information regarding its financial performance [2]. - The complaint highlights that Fly-E's optimistic revenue goals did not align with actual demand for its electric vehicle products, and the company downplayed risks related to lithium batteries, supply chain issues, and regulatory challenges [2]. Financial Performance - On August 14, 2025, Fly-E reported a significant 32% decrease in net revenue compared to the same period in 2024, primarily attributed to a decline in total units sold due to consumer hesitance linked to lithium battery explosion incidents [3]. - Following the revenue announcement, Fly-E's stock price plummeted approximately 87%, from $7.76 per share to $1.00 per share within a single day [3]. Legal Proceedings - Shareholders are encouraged to participate in the class action lawsuit, with options to serve as lead plaintiff or remain as absent class members [4]. - Robbins LLP, the law firm handling the case, operates on a contingency fee basis, meaning shareholders incur no upfront costs [5].

Accessibility StatementSkip Navigation About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Attorney Advertising. Past results do not guarantee a similar outcome. SOURCE Robbins LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- ...

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation for allegedly misleading investors regarding its business prospects and financial guidance during a specific period in 2025 [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that Fluor failed to disclose rising costs associated with key infrastructure projects due to subcontractor design errors, price increases, and scheduling delays [2]. - It is alleged that these issues, along with reduced capital spending from customers and economic uncertainty, significantly impacted Fluor's business and financial results [2]. - Following disappointing financial results for Q2 2025, Fluor revised its financial outlook for FY 2025, projecting adjusted EBITDA of $475 million to $525 million, down from a previous range of $575 million to $675 million, and adjusted EPS of $1.95 to $2.15, down from $2.25 to $2.75 [3]. Group 2: Stock Price Reaction - After the negative financial disclosures, Fluor's stock price dropped by $15.35 per share, or 27.04%, closing at $41.42 per share on August 1, 2025 [3]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their papers by November 14, 2025, to serve as lead plaintiff [4]. - Shareholders can remain absent class members if they choose not to participate in the case [4].